BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 24992547)

  • 1. Montelukast for prevention and treatment of asthma exacerbations in adults: Systematic review and meta-analysis.
    Zhang HP; Jia CE; Lv Y; Gibson PG; Wang G
    Allergy Asthma Proc; 2014; 35(4):278-87. PubMed ID: 24992547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roflumilast combined with montelukast versus montelukast alone as add-on treatment in patients with moderate-to-severe asthma.
    Bateman ED; Goehring UM; Richard F; Watz H
    J Allergy Clin Immunol; 2016 Jul; 138(1):142-149.e8. PubMed ID: 26915674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years.
    Knorr B; Franchi LM; Bisgaard H; Vermeulen JH; LeSouef P; Santanello N; Michele TM; Reiss TF; Nguyen HH; Bratton DL
    Pediatrics; 2001 Sep; 108(3):E48. PubMed ID: 11533366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Daily inhaled corticosteroids or montelukast for preschoolers with asthma or recurrent wheezing: A systematic review.
    Castro-Rodriguez JA; Rodriguez-Martinez CE; Ducharme FM
    Pediatr Pulmonol; 2018 Dec; 53(12):1670-1677. PubMed ID: 30394700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A subgroup analysis of the MONICA study: a 12-month, open-label study of add-on montelukast treatment in asthma patients.
    Virchow JC; Mehta A; Ljungblad L; Mitfessel H
    J Asthma; 2010 Nov; 47(9):986-93. PubMed ID: 20858152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Montelukast: a review of its therapeutic potential in persistent asthma.
    Jarvis B; Markham A
    Drugs; 2000 Apr; 59(4):891-928. PubMed ID: 10804041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized, comparative, multicentric clinical trial to assess the efficacy and safety of zileuton extended-release tablets with montelukast sodium tablets in patients suffering from chronic persistent asthma.
    Kubavat AH; Khippal N; Tak S; Rijhwani P; Bhargava S; Patel T; Shah N; Kshatriya RR; Mittal R
    Am J Ther; 2013; 20(2):154-62. PubMed ID: 22926233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of inhaled corticosteroids and montelukast in children with mild-moderate asthma: results of a systematic review with meta-analysis.
    Castro-Rodriguez JA; Rodrigo GJ
    Arch Dis Child; 2010 May; 95(5):365-70. PubMed ID: 19946008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interventions for autumn exacerbations of asthma in children.
    Pike KC; Akhbari M; Kneale D; Harris KM
    Cochrane Database Syst Rev; 2018 Mar; 3(3):CD012393. PubMed ID: 29518252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Churg-Strauss syndrome in patients receiving montelukast as treatment for asthma.
    Wechsler ME; Finn D; Gunawardena D; Westlake R; Barker A; Haranath SP; Pauwels RA; Kips JC; Drazen JM
    Chest; 2000 Mar; 117(3):708-13. PubMed ID: 10712995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review of recent results of montelukast use as a monotherapy in children with mild asthma.
    Wahn U; Dass SB
    Clin Ther; 2008; 30 Spec No():1026-35. PubMed ID: 18640477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Leukotriene antagonists--do they have a value?].
    Stey C
    Praxis (Bern 1994); 2000 Mar; 89(14):586-90. PubMed ID: 10815466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A placebo-controlled, dose-ranging study of montelukast, a cysteinyl leukotriene-receptor antagonist. Montelukast Asthma Study Group.
    Altman LC; Munk Z; Seltzer J; Noonan N; Shingo S; Zhang J; Reiss TF
    J Allergy Clin Immunol; 1998 Jul; 102(1):50-6. PubMed ID: 9679847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Montelukast improves air trapping, not airway remodeling, in patients with moderate-to-severe asthma: a pilot study.
    Gao JM; Cai F; Peng M; Ma Y; Wang B
    Chin Med J (Engl); 2013 Jun; 126(12):2229-34. PubMed ID: 23786930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammatory markers as exacerbation risk factors after asthma therapy switch from inhaled steroids to montelukast.
    Ciółkowski J; Mazurek H; Hydzik P; Stasiowska B
    Pulm Pharmacol Ther; 2016 Aug; 39():7-13. PubMed ID: 27234706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical trial of low-dose theophylline and montelukast in patients with poorly controlled asthma.
    American Lung Association Asthma Clinical Research Centers
    Am J Respir Crit Care Med; 2007 Feb; 175(3):235-42. PubMed ID: 16998094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Addition of montelukast or salmeterol to fluticasone for protection against asthma attacks: a randomized, double-blind, multicenter study.
    Ilowite J; Webb R; Friedman B; Kerwin E; Bird SR; Hustad CM; Edelman JM
    Ann Allergy Asthma Immunol; 2004 Jun; 92(6):641-8. PubMed ID: 15237766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological management to reduce exacerbations in adults with asthma: a systematic review and meta-analysis.
    Sin DD; Man J; Sharpe H; Gan WQ; Man SF
    JAMA; 2004 Jul; 292(3):367-76. PubMed ID: 15265853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Montelukast improves asthma control in asthmatic children maintained on inhaled corticosteroids.
    Phipatanakul W; Greene C; Downes SJ; Cronin B; Eller TJ; Schneider LC; Irani AM
    Ann Allergy Asthma Immunol; 2003 Jul; 91(1):49-54. PubMed ID: 12877449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Montelukast in the treatment of mild to moderate persistent asthma].
    Bellecoste V; Devouassoux G; Pacheco Y
    Rev Mal Respir; 2011 Jun; 28(6):706-29. PubMed ID: 21742233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.